Transepithelial Photorefractive Keratectomy in Moderate to High Astigmatism With a Non-wavefront–Guided Aberration-Neutral Ablation Profile

光折变性角膜切除术 散光 屈光度 烧蚀 眼科 医学 眼睛畸变 球差 折射误差 角膜地形图 视力 光学 验光服务 镜头(地质) 物理 内科学
作者
Diego de Ortueta,Dennis von Rüden,Shwetabh Verma,Thomas Magnago,Samuel Arba-Mosquera
出处
期刊:Journal of Refractive Surgery [Slack Incorporated (United States)]
卷期号:34 (7): 466-474 被引量:21
标识
DOI:10.3928/1081597x-20180402-04
摘要

To evaluate the outcomes of transepithelial photorefractive keratectomy (PRK) in moderate to high astigmatism with a non-wavefront-guided aberration-neutral ablation profile using SmartPulse allocation.In this retrospective study, myopic patients with a preoperative cylinder of 2.00 diopters (D) or greater were analyzed at 3 months of follow-up. Transepithelial PRK treatments were performed in each patient with the Amaris 1050RS laser (SCHWIND eye-tech-solutions, Kleinostheim, Germany) creating aspheric ablation profiles by applying a SmartPulse allocation. Standard examinations and wavefront analyses were included for low and high ocular residual astigmatism subgroups.Fifty-eight eyes (44 patients) were included in the cohort. The eyes were divided into separate ocular residual astigmatism subgroups: 17 eyes presented with less than 0.50 D (low ocular residual astigmatism) and 24 eyes with greater than 0.75 D (high ocular residual astigmatism). The mean refractive cylinder in the entire cohort was 2.84 ± 0.86 D preoperatively and 0.40 ± 0.39 D postoperatively, with 81% of the eyes within 0.75 D of the target astigmatism. At 3 months of follow-up, significant improvement (P < .05) was seen in terms of sphere, cylinder, spherical equivalent, and uncorrected (UDVA) and corrected (CDVA) distance visual acuity. CDVA improved in 40% of eyes and 3% of eyes lost one line of CDVA. No clinically relevant changes were seen in higher order aberrations. The refractive changes showed an excellent match with the keratometric changes. The difference between the low and high ocular residual astigmatism subgroups was not significant except for the change of Snellen lines of CDVA (P < .05).Transepithelial PRK using a non-wavefront-guided aberration-neutral ablation profile performed by applying SmartPulse allocation yielded excellent visual outcomes. The preoperative astigmatism was reduced to subclinical values. Both subgroups were effective in terms of UDVA, CDVA, spherical and astigmatic correction, and preserving higher order aberrations. However, the low ocular residual astigmatism subgroup was slightly more prone to gain lines of CDVA. [J Refract Surg. 2018;34(7):466-474.].

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
天天快乐应助科研通管家采纳,获得10
2秒前
一行白鹭上青天完成签到 ,获得积分0
4秒前
6秒前
lucky完成签到 ,获得积分10
6秒前
小亮哈哈发布了新的文献求助10
7秒前
陈文学完成签到,获得积分10
12秒前
幸福妙柏完成签到 ,获得积分10
15秒前
几几完成签到,获得积分10
20秒前
fxy完成签到 ,获得积分10
20秒前
絮絮徐完成签到 ,获得积分10
22秒前
yummm完成签到 ,获得积分10
25秒前
上官完成签到 ,获得积分10
27秒前
乐乐应助菠萝采纳,获得10
29秒前
么么完成签到,获得积分10
35秒前
皮皮完成签到 ,获得积分10
36秒前
liao_duoduo完成签到 ,获得积分10
36秒前
菠萝完成签到,获得积分10
36秒前
11完成签到 ,获得积分10
36秒前
笨笨的蓝天完成签到,获得积分10
37秒前
37秒前
菠萝发布了新的文献求助10
42秒前
危机的秋双完成签到 ,获得积分10
43秒前
尤诺完成签到 ,获得积分10
48秒前
甜甜圈完成签到 ,获得积分10
48秒前
tigger完成签到,获得积分10
48秒前
明理夏槐完成签到,获得积分10
51秒前
xczhu完成签到,获得积分10
52秒前
大宝哥哥完成签到 ,获得积分10
54秒前
研友_MLJWvn完成签到 ,获得积分10
57秒前
57秒前
Mushiyu完成签到 ,获得积分10
58秒前
蓝精灵完成签到 ,获得积分10
1分钟前
贝贝完成签到 ,获得积分10
1分钟前
hahaha完成签到,获得积分10
1分钟前
聪慧的石头完成签到,获得积分10
1分钟前
失眠的笑翠完成签到 ,获得积分10
1分钟前
1分钟前
neu_zxy1991完成签到,获得积分10
1分钟前
顾矜应助朝北采纳,获得30
1分钟前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
Modern Epidemiology, Fourth Edition 5000
Kinesiophobia : a new view of chronic pain behavior 5000
Molecular Biology of Cancer: Mechanisms, Targets, and Therapeutics 3000
Digital Twins of Advanced Materials Processing 2000
Propeller Design 2000
Weaponeering, Fourth Edition – Two Volume SET 2000
热门求助领域 (近24小时)
化学 材料科学 医学 生物 工程类 有机化学 纳米技术 化学工程 生物化学 物理 计算机科学 内科学 复合材料 催化作用 物理化学 光电子学 电极 冶金 细胞生物学 基因
热门帖子
关注 科研通微信公众号,转发送积分 6013297
求助须知:如何正确求助?哪些是违规求助? 7580604
关于积分的说明 16140055
捐赠科研通 5160494
什么是DOI,文献DOI怎么找? 2763368
邀请新用户注册赠送积分活动 1743335
关于科研通互助平台的介绍 1634305